Acute hyperglycemia does not impair microvascular reactivity and endothelial function during hyperinsulinemic isoglycemic and hyperglycemic clamp in type 1 diabetic patients

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Horová, Eva ^a   Mazoch, Jií ^a   Hiigertová, Jiina ^a   Kvasnika, Jan ^a   Škrha, Jan ^a   Šoupal, Jan ^a   Prázný, Martin ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; FIBRINOGEN; INSULIN ASPART; INSULIN LISPRO; LIPID; INSULIN;

ACUTE DISEASE; ADULT; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPEREMIA; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULINEMIA; LASER DOPPLER FLOWMETRY; MICROVASCULAR ENDOTHELIAL CELL; MICROVASCULATURE; PERFUSION; PRIORITY JOURNAL; CALIBRATION; CYTOLOGY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METABOLISM; METHODOLOGY; MICROCIRCULATION; MIDDLE AGED; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADULT; BLOOD GLUCOSE; CALIBRATION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; ENDOTHELIUM, VASCULAR; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERGLYCEMIA; INSULIN; LASER-DOPPLER FLOWMETRY; MICROCIRCULATION; MIDDLE AGED; OXIDATIVE STRESS; PERFUSION;

EID: 84856402451     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/851487     Document Type: Article

References (43)

1. Holman R. R., Paul S. K., Bethel M. A., Matthews D. R., Neil H. A. W., 10-Year follow-up of intensive glucose control in type 2 diabetes The New England Journal of Medicine 2008 359 15 1577 1589
2. The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus The New England Journal of Medicine 1993 329 14 977 986
3. UK Prospective Diabetes Study Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 1998 352 9131 837 853
4. Nathan D. M., Cleary P. A., Backlund J. Y. C., Genuth S. M., Lachin J. M., Orchard T. J., Raskin P., Zinman B., Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes The New England Journal of Medicine 2005 353 25 2643 2653 (Pubitemid 41817713)
5. Muggeo M., Zoppini G., Bonora E., Brun E., Bonadonna R. C., Moghetti P., Verlato G., Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study Diabetes Care 2000 23 1 45 50 (Pubitemid 30022893)
6. Muggeo M., Verlato G., Bonora E., Zoppini G., Corbellini M., De Marco R., Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the verona diabetes study Circulation 1997 96 6 1750 1754 (Pubitemid 27400729)
7. Gimeno-Orna J. A., Castro-Alonso F. J., Boned-Juliani B., Lou-Arnal L. M., Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients Journal of Diabetes and Its Complications 2003 17 2 78 81 (Pubitemid 36279504)
8. Takao T., Ide T., Yanagisawa H., Kikuchi M., Kawazu S., Matsuyama Y., The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up Diabetes Research and Clinical Practice 2010 89 3 296 302
9. Bragd J., Adamson U., Bcklund L. B., Lins P. E., Moberg E., Oskarsson P., Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type1 diabetes over a decade? Diabetes and Metabolism 2008 34 6 612 616
10. Kilpatrick E. S., Rigby A. S., Atkin S. L., The effect of glucose variability on the risk of microvascular complications in type 1 diabetes Diabetes Care 2006 29 7 1486 1490 (Pubitemid 44127568)
11. Siegelaar S. E., Kilpatrick E. S., Rigby A. S., Atkin S. L., Hoekstra J. B. L., Devries J. H., Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT Diabetologia 2009 52 10 2229 2232
12. Brownlee M., Biochemistry and molecular cell biology of diabetic complications Nature 2001 414 6865 813 820 (Pubitemid 34000785)
13. Brownlee M., Hirsch I. B., Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications Journal of the American Medical Association 2006 295 14 1707 1708
14. Quagliaro L., Piconi L., Assaloni R., Martinelli L., Motz E., Ceriello A., Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation Diabetes 2003 52 11 2795 2804 (Pubitemid 37339710)
15. Risso A., Mercuri F., Quagliaro L., Damante G., Ceriello A., Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture American Journal of PhysiologyEndocrinology and Metabolism 2001 281 5 E924 E930
16. Wentholt I. M. E., Kulik W., Michels R. P. J., Hoekstra J. B. L., DeVries J. H., Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes Diabetologia 2008 51 1 183 190 (Pubitemid 50002199)
17. Ceriello A., Esposito K., Piconi L., Ihnat M. A., Thorpe J. E., Testa R., Boemi M., Giugliano D., Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients Diabetes 2008 57 5 1349 1354
18. Monnier L., Mas E., Ginet C., Michel F., Villon L., Cristol J. P., Colette C., Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes Journal of the American Medical Association 2006 295 14 1681 1687
19. Rask-Madsen C., King G. L., Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes Nature Clinical Practice Endocrinology and Metabolism 2007 3 1 46 56 (Pubitemid 46006612)
20. Wassink A. M. J., Olijhoek J. K., Visseren F. L. J., The metabolic syndrome: metabolic changes with vascular consequences European Journal of Clinical Investigation 2007 37 1 8 17 (Pubitemid 44934767)
21. Joshua I. G., Zhang Q., Falcone J. C., Bratcher A. P., Rodriguez W. E., Tyagi S. C., Mechanisms of endothelial dysfunction with development of type 1 diabetes mellitus: role of insulin and C-peptide Journal of Cellular Biochemistry 2005 96 6 1149 1156 (Pubitemid 41681857)
22. Oomen P. H. N., Kant G. D., Dullaart R. P. F., Reitsma W. D., Smit A. J., Acute hyperglycemia and hyperinsulinemia enhance vasodilatation in type 1 diabetes mellitus without increasing capillary permeability and inducing endothelial dysfunction Microvascular Research 2002 63 1 1 9 (Pubitemid 34971503)
23. Chittari M. V., McTernan P., Bawazeer N., Impact of acute hyperglycaemia on endothelial function and retinal vascular reactivity in patients with Type 2 diabetes Diabetic Medicine 2011 28 4 450 454
24. Dandona P., Chaudhuri A., Ghanim H., Mohanty P., Insulin as an anti-inflammatory and antiatherogenic modulator Journal of the American College of Cardiology 2009 53 supplement 5 S14 S20
25. Kuboki K., Jiang Z. Y., Takahara N., Ha S. W., Igarashi M., Yamauchi T., Feener E. P., Herbert T. P., Rhodes C. J., King G. L., Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivoa specific vascular action of insulin Circulation 2000 101 6 676 681 (Pubitemid 30094740)
26. Monnier L., Colette C., Mas E., Michel F., Cristol J. P., Boegner C., Owens D. R., Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy Diabetologia 2010 53 3 562 571
27. DeFronzo R. A., Tobin J. D., Andres R., Glucose clamp technique: a method for quantifying insulin secretion and resistance The American Journal of Physiology 1979 237 3 E214 E223
28. indelka G., krha J., Przn M., Haas T., Association of obesity, diabetes, serum lipids and blood pressure regulates insulin action Physiological Research 2002 51 1 85 91 (Pubitemid 34266447)
29. Yagi K., A simple fluorometric assay for lipoperoxide in blood plasma Biochemical Medicine 1976 15 2 212 216
30. Clauss A., A rapid physiological coagulation method for the determination of plasma fibrinogen Lancet 1951 2 501
31. Freccero C., Holmlund F., Bornmyr S., Castenfors J., Johansson A. M., Sundkvist G., Svensson H., Wollmer P., Laser Doppler perfusion monitoring of skin blood flow at different depths in finger and arm upon local heating Microvascular Research 2003 66 3 183 189 (Pubitemid 37373592)
32. Meigs J. B., O'Donnell C. J., Tofler G. H., Benjamin E. J., Fox C. S., Lipinska I., Nathan D. M., Sullivan L. M., D'Agostino R. B., Wilson P. W. F., Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study Diabetes 2006 55 2 530 537 (Pubitemid 43343286)
33. Brownlee M., The pathobiology of diabetic complications: a unifying mechanism Diabetes 2005 54 6 1615 1625 (Pubitemid 40770750)
34. krha J., Przn M., Haas T., Kvasnika J., Kalvodov B., Comparison of laser-Doppler flowmetry with biochemical indicators of endothelial dysfunction related to early microangiopathy in Type 1 diabetic patients Journal of Diabetes and Its Complications 2001 15 5 234 240 (Pubitemid 32750610)
35. krha J., Diabetes and vascular disease: from pathogenesis to treatment. Are vascular effects of hypoglycemic and hypolipidemic drugs independent of their metabolic effects? Diabetes and Metabolic Syndrome 2007 1 1 61 69
36. Kotzailias N., Graninger M., Knechtelsdorfer M., Jilma B., Acute effects of hyperglycaemia on plasma concentration of soluble P-selectin and von Willebrand Factor in healthy volunteers -a prospective randomised double blind controlled study Thrombosis Research 2009 123 3 452 459
37. Undas A., Wiek I., Stpie E., Zmudka K., Tracz W., Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome Diabetes Care 2008 31 8 1590 1595
38. Vaidyula V. R., Boden G., Rao A. K., Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects Platelets 2006 17 8 577 585 (Pubitemid 44837728)
39. Vaidyula V. R., Rao A. K., Mozzoli M., Homko C., Cheung P., Boden G., Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand Diabetes 2006 55 1 202 208 (Pubitemid 43343316)
40. Blann A. D., Nadar S. K., Lip G. Y. H., The adhesion molecule P-selectin and cardiovascular disease European Heart Journal 2003 24 24 2166 2179 (Pubitemid 37522669)
41. Weyer C., Bogardus C., Mott D. M., Pratley R. E., The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus Journal of Clinical Investigation 1999 104 6 787 794 (Pubitemid 29536364)
42. Donath M. Y., Halban P. A., Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications Diabetologia 2004 47 3 581 589 (Pubitemid 38491259)
43. Geddes J., Schopman J. E., Zammitt N. N., Frier B. M., Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes Diabetic Medicine 2008 25 4 501 504 (Pubitemid 351490123)